Kamron Laboratories has informed that the next Meeting of the Board of Directors of the Company to consider and approve the Standalone Audited Financial Results of the Company for the financial year 2015-16 ended on March 31, 2016 is scheduled to be held on May 30, 2016. Further, pursuant to Code of Prevention for Insider Trading of the Company and applicable SEBI Regulations, the Company has informed all the designated employees and Directors that trading window for dealing in securities of the Company will be closed from May 10, 2016 to May 31, 2016.
The above information is a part of company’s filings submitted to BSE.
